| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.19 | 0.002 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.096 | 0.004 |